NCT04277858View on ClinicalTrials.gov

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2026

Conditions
Oropharynx CancerTonsil CancerThroat CancerBase of the Tongue Carcinoma
Interventions
DRUG

Docetaxel

Subjects will be treated with neoadjuvant docetaxel and cisplatin for 3 cycles. This is followed by transoral robotic surgery (TORS) and neck dissection as definitive treatment, reserving radiotherapy for salvage.

Trial Locations (1)

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

Nader Sadeghi

OTHER